Literature DB >> 20339160

Oropharyngeal carcinoma related to human papillomavirus.

Hisham Mehanna, Terence M Jones, Vincent Gregoire, K Kian Ang.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20339160     DOI： 10.1136/bmj.c1439

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

1.  Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy.

Authors:  Michael D Story; Jing Wang
Journal:  Int J Part Ther       Date:  2018

2.  Human papillomavirus-16 (HPV-16) infection association with CIAP-2 expression in head and neck cancer.

Authors:  Amal Mansour; Marwa Ali; Hussein Helmy; Samar Kassim
Journal:  Med Oncol       Date:  2012-01-04       Impact factor: 3.064

3.  Radiotherapy-induced xerostomia, pre-clinical promise of LMS-611.

Authors:  Claire Paterson; B Caldwell; S Porteous; A McLean; C M Messow; M Thomson
Journal:  Support Care Cancer       Date:  2015-07-05       Impact factor: 3.603

4.  Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.

Authors:  Andrew G Schache; Triantafilos Liloglou; Janet M Risk; Anastasia Filia; Terence M Jones; Jon Sheard; Julia A Woolgar; Timothy R Helliwell; Asterios Triantafyllou; Max Robinson; Philip Sloan; Colin Harvey-Woodworth; Daniel Sisson; Richard J Shaw
Journal:  Clin Cancer Res       Date:  2011-10-01       Impact factor: 12.531

5.  HPV vaccination and cervical cancer.

Authors:  Anne Szarewski
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

6.  Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.

Authors:  Vlad C Sandulache; John Hamblin; Syeling Lai; Todd Pezzi; Heath D Skinner; Numan A Khan; Shayan M Dioun; Christine Hartman; Jennifer Kramer; Elizabeth Chiao; Xiaodong Zhou; Jose P Zevallos
Journal:  Head Neck       Date:  2015-07-04       Impact factor: 3.147

7.  Predictors of quality of life in head and neck cancer survivors up to 5 years after end of treatment: a cross-sectional survey.

Authors:  Mary Wells; Samantha Swartzman; Heidi Lang; Margaret Cunningham; Lesley Taylor; Jane Thomson; Julie Philp; Colin McCowan
Journal:  Support Care Cancer       Date:  2015-12-11       Impact factor: 3.603

8.  Palbociclib Renders Human Papilloma Virus-Negative Head and Neck Squamous Cell Carcinoma Vulnerable to the Senolytic Agent Navitoclax.

Authors:  Nicholas J Gadsden; Cory D Fulcher; Daniel Li; Nitisha Shrivastava; Carlos Thomas; Jeffrey E Segall; Michael B Prystowsky; Nicolas F Schlecht; Evripidis Gavathiotis; Thomas J Ow
Journal:  Mol Cancer Res       Date:  2021-01-25       Impact factor: 5.852

9.  Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Authors:  Rémi Marty; Stéphane Roze; Xavier Bresse; Nathalie Largeron; Jayne Smith-Palmer
Journal:  BMC Cancer       Date:  2013-01-08       Impact factor: 4.430

10.  A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer.

Authors:  Robin J D Prestwich; Kiran Kancherla; Didem Colpan Oksuz; Deborah Williamson; Karen E Dyker; Catherine Coyle; Mehmet Sen
Journal:  Radiat Oncol       Date:  2010-12-21       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.